Clinical Trial Update: Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating STSP-0601 for injection in hemophilia patients is currently recruiting; sponsor is Jiangsu BioJeTay Biotechnology Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• STSP-0601 (STSP-0601)

Snippet

Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd. | Conditions: Hemophilia | Phase 3 | Status: RECRUITING